[25-012698] the lab requires antibodies in order to for immune cell distribution and function in sleep study.

Ended Purchase Order Awarded Last action

Contract number
75N92025P00301
Awardee
Awarding agency
Obligated
$23,027

Award facts

Contract value 100% obligated
$23,026.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This is a $23,026.80 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and research products. The contract is to provide antibodies required for a sleep study involving immune cell distribution and function. The contract has a period of performance ending on November 5, 2025 and was awarded on August 6, 2025. No set-aside designation was used for this award.

Quick answers

Who was awarded contract 75N92025P00301?

75N92025P00301 was awarded to Biolegend, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 6, 2025.

How much is contract 75N92025P00301 worth?

The government has obligated $23,027 on 75N92025P00301.

Was contract 75N92025P00301 competed?

The extent of competition for 75N92025P00301 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login